143 filings
ARS
2023 FY
VIR
Vir Biotechnology Inc
19 Apr 24
Annual report to shareholders
8:40am
DEFA14A
VIR
Vir Biotechnology Inc
19 Apr 24
Additional proxy soliciting materials
8:35am
DEF 14A
VIR
Vir Biotechnology Inc
Definitive proxy
19 Apr 24
8:32am
8-K
VIR
Vir Biotechnology Inc
18 Apr 24
Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy
8:44am
S-8
VIR
Vir Biotechnology Inc
26 Feb 24
Registration of securities for employees
4:27pm
8-K
46n3nt621uqj36dge2t
22 Feb 24
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
4:12pm
8-K
apjhnn
20 Feb 24
Departure of Directors or Certain Officers
4:33pm
8-K
f27d bf0e
13 Dec 23
Cost Associated with Exit or Disposal Activities
4:06pm
8-K
la6mwt 8053pvdh
3 Nov 23
Entry into a Material Definitive Agreement
4:37pm
S-3ASR
8nu7x7
3 Nov 23
Automatic shelf registration
4:33pm
8-K
n2fl0cd6kr tw6q8ebt
2 Nov 23
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2023 Financial Results
4:09pm
8-K
15n1q
3 Oct 23
Entry into a Material Definitive Agreement
8:01am
8-K
i1khh5biiq2c
20 Sep 23
Departure of Directors or Certain Officers
6:02am
8-K
6cmmwn 2hp31q
3 Aug 23
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2023 Financial Results
4:14pm
8-K
rlw e2zrhxm49u9x
20 Jul 23
Vir Biotechnology Announces Topline Data from Phase 2 PENINSULA Trial Evaluating
8:04am
8-K
pvq gtos3t4qaxay
23 May 23
Submission of Matters to a Vote of Security Holders
4:06pm